International Clinical Trials Day 2019
20 May 2019
Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.
We want to take today to say a special thank you to our wonderful Clinical Trials team, and extend our appreciation to the many thousands of dedicated people that undertake clinical trials to advance medicine and treatments for patients. Today is also an opportunity to recognise patients and their contribution to finding a cure by choosing to participate in our trials.
Our 20-person team based at the Poche Centre is currently coordinating 18 actively recruiting trials, while maintaining follow-up for a further 23. The trials coordinated by the team range from surgical and dermatological trials, through the spectrum of available medical and radiation oncology trials, including immunotherapy, targeted therapy, and radiation therapy. In 2018, 244 new patients were enrolled in clinical trials at MIA, while 665 were in the follow-up stages.
“We are very fortunate here at MIA to have an extremely hardworking and inspiring Clinical Trials team who are one hundred percent dedicated to our patients,” says Co-Medical Director Professor Richard Scolyer.
Co-Medical Director Professor Georgina Long adds, “Clinical trials lead to advances in treatment that create better outcomes for our patients – continually pushing the boundaries and conducting these trials is what is going to help us achieve our goal of zero deaths of melanoma.”
International Clinical Trials Day commemorates the day Scottish doctor James Lind began the first ever clinical trial in 1747, using different groups of sailors to identify the link between fruit and the prevention of scurvy. Lind changed modern medicine with his study, so every year International Clinical Trials Day is celebrated to appreciate and highlight the work of those in Clinical Trials.
Clinical Trials Manager Maria Gonzalez echoed the sentiments of the whole team, “We all come to work each day for the same reason: to help patients and find a cure.”
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread
Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.
COVID restrictions continue to impact fundraising for melanoma services in Riverina.
Ben Garrow lost his life to melanoma. In his honour his family has established a scholarship to support a PhD student whose work focuses on saving lives from melanoma.
More than 150 clinicians, researchers and MIA staff gathered online to share research highlights.
Independent researchers at The University of Sydney are seeking patient feedback.
A re-cap of the wonderful, and often very creative, community fundraising initiatives over the April to June quarter.
Our patients who donate their tissue samples and records to our research are helping to make a difference to the lives of future melanoma patients.
MIA researchers have recently been awarded two competitive funding grants, which will help facilitate their ground-breaking work in melanoma research.
Celebrate the 10th anniversary of Amie St Clair Melanoma at the Annual Ball in Wagga Wagga!
Postponed to early 2022. Melanoma survivor Matt Kean is doing a 1000km bike ride around the Riverina to increase awareness of melanoma and raise funds for Amie St Clair Melanoma - MIA. There are many ways you can be part of this life-changing ride!
Riverina patients gain access to potentially life saving immunotherapy treatment close to home.
MIA's Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia.
In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.
Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.
The easing of COVID restrictions has meant the return of community events, and we recognise the generous support of our community fundraisers.
Melanoma patients and their carers are being urged to participate in a ground-breaking survey which will shape the future of melanoma treatment, research, support and funding in Australia.